Known targets — ChEMBL curated mechanism
ABL1ACEACHEACVR1ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALKAVPR1AAVPR2BCHEBCRCA2CACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCASRCCR5CDK4CDK6CFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNA3CHRNA7CHRNB1CHRNB4CHRNDCHRNECHRNGCOXFA4COXFA4L2CRBNCSF1RCUL4ACYP19A1DDB1DPP4DRD1DRD2DRD3DRD4EDNRAEGFREML4ERBB2ERBB4ESR1ESR2FGFR1FGFR3FLT1FLT3FLT4GAAGABRA1GABRA2GABRA3GABRA4GABRA5GABRA6GABRB1GABRB2GABRB3GABRDGABREGABRG1GABRG2GABRG3GABRPGABRQGHSRGLAGNRHRGPD2GRIN1GRIN2AGRIN2BGRIN2CGRIN2DGRIN3AGRIN3BGSTP1HCN4HCRTR1HCRTR2HDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HRH2HRH3HSD11B1HSP90AA1HSP90AB1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IMPDH1IMPDH2ITGA2BITGB3ITKJAK1JAK2KCNA1KCNA10KCNA2KCNA3KCNA4KCNA5KCNA6KCNA7KCNB1KCNB2KCNC1KCNC2KCNC3KCNC4KCND1KCND2KCND3KCNF1KCNG1KCNG2KCNG3KCNG4KCNH1KCNH2KCNH3KCNH4KCNH5KCNH6KCNH7KCNH8KCNJ2KCNJ3KCNJ5KCNK3KCNK9KCNQ1KCNQ2KCNQ3KCNQ4KCNQ5KCNS1KCNS2KCNS3KCNV1KCNV2KDRKITKLKB1LCKMMAOAMAOBMAPK14METMMP1MMP13MMP7MMP8MT-ND1MT-ND2MT-ND3MT-ND4MT-ND4LMT-ND5MT-ND6NDUFA1NDUFA10NDUFA11NDUFA12NDUFA13NDUFA2NDUFA3NDUFA5NDUFA6NDUFA7NDUFA8NDUFA9NDUFAB1NDUFAF1NDUFAF2NDUFAF3NDUFAF4NDUFB1NDUFB10NDUFB11NDUFB2NDUFB3NDUFB4NDUFB5NDUFB6NDUFB7NDUFB8NDUFB9NDUFC1NDUFC2NDUFS1NDUFS2NDUFS3NDUFS4NDUFS5NDUFS6NDUFS7NDUFS8NDUFV1NDUFV2NDUFV3NR3C1NS5ANTRK1NTRK2NTRK3ODC1OPRD1OPRK1OPRM1P2RY12PAHPARP1PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDE5APDE7APDE7BPDE8APDE8BPDGFRAPDGFRBPIK3CAPIK3CDPNPPOLA1POLA2POLD1POLD2POLD3POLD4POLEPOLE2POLE3PPARGPRIM1PRIM2PRKCAPRKCBPRKCDPRKCEPRKCGPRKCHPRKCIPRKCQPRKCZPRKD1PRKD3PTGS1PTGS2RBX1RENRETROCK1ROCK2RPE65RRM1RRM2RRM2BS1PR1S1PR2S1PR3S1PR4S1PR5SCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC18A2SLC6A1SLC6A2SLC6A3SLC6A4SLC9A3SRCTACR1TOP1TOP2ATOP2BTTRTYMPdacAdacBdacCembAfolAftsIgyrAgyrBmrcAmrcBmrdAparCparEpolrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUykgMykgO
The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.
Predicted protein targets (top 5)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | LMNA | P02545 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL148930 | 0.96 | MEN1 (0.47) | MEN1LMNAKMT2AALDH1A1TSHR | |
| Water SCHEMBL1204724 | 0.92 | MEN1 (0.44) | MEN1LMNAKMT2AALDH1A1TSHR | |
| Bromide SCHEMBL15820403 | 0.92 | MEN1 (0.44) | MEN1LMNAKMT2AALDH1A1TSHR | |
| Hydrochloric Acid SCHEMBL11315659 | 0.87 | ALDH1A1 (0.39) | MEN1LMNAKMT2AALDH1A1TSHR | |
| Tromethamine SCHEMBL1933899 | 0.86 | MEN1 (0.67) | MEN1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL2138443 | 0.86 | MEN1 (0.56) | MEN1LMNAKMT2A | |
| Hydrochloric Acid SCHEMBL8432627 | 0.86 | MEN1 (0.56) | MEN1LMNAKMT2A | |
| SCHEMBL5056997 | 0.83 | LMNA (0.37) | MEN1LMNAKMT2AALDH1A1TSHR | |
| SCHEMBL2351528 | 0.83 | MEN1 (0.37) | MEN1LMNAKMT2A | |
| Bicarbonate SCHEMBL8995795 | 0.83 | ARG2 (0.39) | MEN1LMNAKMT2AALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 36 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4204609-B1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC (US) | 2026-05-27 | — | — | EP | claimed |
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC (US) | 2026-03-19 | — | — | US | claimed |
| US-20240318342-A1 | COMPOSITIONS AND METHODS FOR THE ELETRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC. | 2024-09-26 | — | — | US | claimed |
| WO-2024081584-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC. (US) | 2024-04-18 | — | — | WO | claimed |
| US-20240110306-A1 | Compositions and Methods for the Electrodeposition of Nanotwinned Copper | MACDERMID ENTHONE INC (US) | 2024-04-04 | — | — | US | claimed |
| US-11873568-B2 | Compositions and methods for the electrodeposition of nanotwinned copper | MACDERMID ENTHONE INC. (US) | 2024-01-16 | — | — | US | claimed |
| CN-115781843-A | Water-based flame-retardant treating agent and preparation method thereof | 贵州洪乘宇科技有限责任公司 | 2023-03-14 | — | — | CN | claimed |
| US-20220298665-A1 | Compositions and Methods for the Electrodeposition of Nanotwinned Copper | MACDERMID ENTHONE INC (US) | 2022-09-22 | — | — | US | claimed |
| US-11384446-B2 | Compositions and methods for the electrodeposition of nanotwinned copper | MACDERMID ENTHONE INC. (US) | 2022-07-12 | — | — | US | claimed |
| US-5242463-A | Fibers, threads, linters, roving, fabrics, yarns, slivers and paper | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1993-09-07 | — | — | US | claimed |
| EP-4204609-B1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC (US) | 2026-05-27 | — | — | EP | disclosed |
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | MACDERMID ENTHONE INC (US) | 2026-03-19 | — | — | US | disclosed |
| EP-4567075-A1 | CURABLE COMPOSITION | Kaneka Corporation (JP) | 2025-06-11 | — | — | EP | disclosed |
| US-20240318342-A1 | COMPOSITIONS AND METHODS FOR THE ELETRODEPOSITION OF NANOTWINNED COPPER | MACDERMID ENTHONE INC. | 2024-09-26 | — | — | US | disclosed |
| EP-4381120-A1 | COMPOSITIONS AND METHODS FOR THE ELECTRODEPOSITION OF NANOTWINNED COPPER | MacDermid Enthone Inc. (US) | 2024-06-12 | — | — | EP | disclosed |
| US-5242463-A | Fibers, threads, linters, roving, fabrics, yarns, slivers and paper | THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF AGRICULTURE (US) | 1993-09-07 | — | — | US | disclosed |
| EP-0365595-A4 | AFFINITY REMOVAL OF CONTAMINATING SEQUENCES FROM RECOMBINANT CLONED NA USING CAPTURE BEADS. | DU PONT (US) | 1990-06-05 | — | — | EP | disclosed |
| EP-0365595-A1 | AFFINITY REMOVAL OF CONTAMINATING SEQUENCES FROM RECOMBINANT CLONED NA USING CAPTURE BEADS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1990-05-02 | — | — | EP | disclosed |
| WO-1988010313-A1 | AFFINITY REMOVAL OF CONTAMINATING SEQUENCES FROM RECOMBINANT CLONED NA USING CAPTURE BEADS | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 1988-12-29 | — | — | WO | disclosed |
| US-4264364-A | A COMPLEX OF A FRIEDEL-CRAFTS HALIDE WITH AN ORGANIC COMPOUND COMPRISING A QUATERNARY AMMONIUM, A PHOSPHONIUM, A SULFONIUM, OR AN ORTHO SILICATE COMPOUND | INDIAN HEAD INC. (US) | 1981-04-28 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260078517-A1 | COMPOSITION AND METHOD FOR NANOTWINNED COPPER FORMATION | AOC2, HCN2, STMN2 | MEN1 979/4885LMNA 3174/4885KMT2A 2633/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.